Dear Doctor letter on Invirase® (active substance: saquinavir): QT-prolongations
updated: 2010.07.15
Additional safety information on the arrhythmogenic risk due to QT and PR interval prolongations in association with Invirase (saquinavir).
risk information - full text (available in German only)